[Coin World] Predictive Oncology Inc. (NASDAQ: POAI) raised approximately $344.4 million through a private sale and launched a digital asset funding strategy focusing on the native Token ATH of the decentralized infrastructure network Aethir. CEO Raymond Vennare described the collaboration as a "landmark event" for expanding core business opportunities, while Aethir's co-founder emphasized POAI's role as an ecosystem operator. Following the announcement, POAI's stock price surged 198.71%, with an Opening Price of $2.1350, before pulling back to $1.34. Meanwhile, the ATH Token rose over 75% within a month, trading at $0.05491, and Aethir's monthly revenue hit a record high of $13 million, with a total duration exceeding 1.16 billion hours.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
POAI raised $340 million focusing on ATH Token, with the price rising nearly 200%.
[Coin World] Predictive Oncology Inc. (NASDAQ: POAI) raised approximately $344.4 million through a private sale and launched a digital asset funding strategy focusing on the native Token ATH of the decentralized infrastructure network Aethir. CEO Raymond Vennare described the collaboration as a "landmark event" for expanding core business opportunities, while Aethir's co-founder emphasized POAI's role as an ecosystem operator. Following the announcement, POAI's stock price surged 198.71%, with an Opening Price of $2.1350, before pulling back to $1.34. Meanwhile, the ATH Token rose over 75% within a month, trading at $0.05491, and Aethir's monthly revenue hit a record high of $13 million, with a total duration exceeding 1.16 billion hours.